(Q35913613)
Statements
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study (English)
R Katherine Alpaugh
Michael W Sill
Kathleen M Darcy
Stephen C Rubin
Robert S Mannel
Steven Waggoner
Russell J Schilder
Kathy Q Cai
Andrew K Godwin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference